Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions

Open-Label Adalimumab for Ulcerative Colitis Patients

NCT00421642 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis

NCT02065557 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

NCT01550965 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

NCT02163759 ·Status: COMPLETED ·Phase: PHASE3

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

NCT01848561 ·Status: ACTIVE_NOT_RECRUITING

A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis

NCT03398135 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Prognosis in UC After First Biological

NCT05530122 ·Status: COMPLETED

Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis

NCT02289417 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT02819635 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis

NCT06269185 ·Status: COMPLETED

Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis

NCT01494857 ·Status: UNKNOWN ·Phase: PHASE3

Determination of the Optimal Treatment Target in Ulcerative Colitis

NCT04259138 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

NCT03006068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

NCT03653026 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients

NCT02129439 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

NCT02171429 ·Status: COMPLETED ·Phase: PHASE3

A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab

NCT04183608 ·Status: RECRUITING ·Phase: PHASE4

Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon

NCT00348283 ·Status: COMPLETED ·Phase: PHASE3

Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis

NCT03142113 ·Status: COMPLETED

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

NCT04613518 ·Status: COMPLETED ·Phase: PHASE2

An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)

NCT05084261 ·Status: COMPLETED ·Phase: PHASE1

Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis

NCT02506179 ·Status: COMPLETED

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

NCT03464136 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

NCT04987307 ·Status: TERMINATED ·Phase: PHASE2

Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis

NCT03893565 ·Status: TERMINATED ·Phase: PHASE2